Mölnlycke Health Care supports the goals of the recently-announced World Health Organisation policy to combat the spread of antimicrobial resistance.
Within its six point strategy, the WHO calls for improved infection control practices, including hand hygiene, barrier precautions, aseptic practices and environmental hygiene and waste management. The organisation calls on health-care policy makers, the public, health care professionals and the pharmaceutical industry to take immediate steps to counter this emerging threat.
As one of the world's leading providers of single-use surgical and wound care products, Mölnlycke Health Care is a champion of optimal infection control practices. Alongside its heritage in developing market-leading brands, such as HiBi® antiseptics and Biogel® surgical gloves, the company actively drives a series of global initiatives to reduce the unnecessary spread of infection in the surgical setting. Mölnlycke Health Care also markets a highly-effective range of topical antimicrobial dressings, as Mepilex®, in the wound care setting. These dressings help caregivers to manage or prevent wound infections locally, thereby avoiding the widespread use of systemic antibiotics which increasingly places future antibiotic effectiveness in jeopardy.
The WHO policy was made public on its annual "World Health Day" on 7 April 2011, warning that urgent action is required to avoid a global regression into a "pre-antibiotic era". Inappropriate use of infection-fighting drugs and poor infection control are argued to be among the leading causes of antimicrobial resistance and are a rapidly-growing concern that threaten life-saving medicines.
Read the WHO's policy document on Enhancing Infection Control.